Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Aditi Mulgaonkar"'
Autor:
Shahab Ranjbar Bahadori, Ryan Hart, Aditi Mulgaonkar, Yunfeng Wang, Samuel Fuentes, Yi Hong, Ye Cao, Jiechao Jiang, Xiankai Sun, Yaowu Hao
Publikováno v:
Crystals, Vol 14, Iss 3, p 240 (2024)
We report a simple synthesis process for a wide variety of ultrasmall nanocrystals. Simply immersing a dialysis bag containing an aqueous solution of a metal salt mixed with citric acid in a NaOH solution reservoir for 10 min, nanocrystals measuring
Externí odkaz:
https://doaj.org/article/64b1c5b244b940a1963e9e36896053e0
Autor:
Aditi Mulgaonkar, Durga Udayakumar, Yaxing Yang, Shelby Harris, Orhan K. Öz, Praveen Ramakrishnan Geethakumari, Xiankai Sun
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Chimeric antigen receptor (CAR) T-cell therapies have evolved as breakthrough treatment options for the management of hematological malignancies and are also being developed as therapeutics for solid tumors. However, despite the impressive patient re
Externí odkaz:
https://doaj.org/article/f1f1996dcbf2454e873de44322b482f4
Autor:
Joseph Vento, Aditi Mulgaonkar, Layton Woolford, Kien Nham, Alana Christie, Aditya Bagrodia, Alberto Diaz de Leon, Raquibul Hannan, Isaac Bowman, Renee M. McKay, Payal Kapur, Guiyang Hao, Xiankai Sun, James Brugarolas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-6 (2019)
Abstract Background Programmed death-ligand 1 (PD-L1) expression in metastatic renal cell carcinoma (RCC) correlates with a worse prognosis, but whether it also predicts responsiveness to anti-PD-1/PD-L1 therapy remains unclear. Most studies of PD-L1
Externí odkaz:
https://doaj.org/article/8c4fd226b847427c8134b2fba28b7121
Autor:
Xiaofei Gao, Zhaohuan Zhang, Tomoyuki Mashimo, Bo Shen, James Nyagilo, Hao Wang, Yihui Wang, Zhida Liu, Aditi Mulgaonkar, Xiao-Ling Hu, Sara G.M. Piccirillo, Ugur Eskiocak, Digant P. Davé, Song Qin, Yongjie Yang, Xiankai Sun, Yang-Xin Fu, Hui Zong, Wenzhi Sun, Robert M. Bachoo, Woo-ping Ge
Publikováno v:
Cell Reports, Vol 30, Iss 8, Pp 2489-2500.e5 (2020)
Summary: Emerging evidence suggests that crosstalk between glioma cells and the brain microenvironment may influence brain tumor growth. To date, known reciprocal interactions among these cells have been limited to the release of paracrine factors. C
Externí odkaz:
https://doaj.org/article/bbf1b45e59a14c7fa609bc4ef41b8bc0
Autor:
Cynthia M. Co, Aditi Mulgaonkar, Ning Zhou, Shelby Harris, Orhan K. Öz, Liping Tang, Xiankai Sun
Publikováno v:
ACS Infectious Diseases. 8:1663-1673
Autor:
Xiankai Sun, James Brugarolas, Guiyang Hao, Christina Stevens, I. Alex Bowman, Nirmish Singla, Vanina T. Tcheuyap, Alana Christie, Payal Kapur, Kien Nham, Bing Guan, Layton Woolford, Roy Elias, Aditi Mulgaonkar
Supplementary Table from ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702b5730fdf898803eaa09b5ebbc6071
https://doi.org/10.1158/1078-0432.22489257.v1
https://doi.org/10.1158/1078-0432.22489257.v1
Autor:
Xiankai Sun, James Brugarolas, Guiyang Hao, Christina Stevens, I. Alex Bowman, Nirmish Singla, Vanina T. Tcheuyap, Alana Christie, Payal Kapur, Kien Nham, Bing Guan, Layton Woolford, Roy Elias, Aditi Mulgaonkar
Purpose:Immune checkpoint inhibitors (ICI) targeting the programmed cell death protein 1 and its ligand (PD-1/PD-L1) have transformed the treatment paradigm for metastatic renal cell carcinoma (RCC). However, response rates to ICIs as single agents o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b07b3d292a34ae6f6fc9ab155467fd
https://doi.org/10.1158/1078-0432.c.6532917
https://doi.org/10.1158/1078-0432.c.6532917
Autor:
Xiankai Sun, James Brugarolas, Guiyang Hao, Christina Stevens, I. Alex Bowman, Nirmish Singla, Vanina T. Tcheuyap, Alana Christie, Payal Kapur, Kien Nham, Bing Guan, Layton Woolford, Roy Elias, Aditi Mulgaonkar
Supplementary Figure from ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37118b799a1cfafe59d06c481fac6415
https://doi.org/10.1158/1078-0432.22489272.v1
https://doi.org/10.1158/1078-0432.22489272.v1
Autor:
Aditi Mulgaonkar, Roy Elias, Layton Woolford, Bing Guan, Kien Nham, Payal Kapur, Alana Christie, Vanina T. Tcheuyap, Nirmish Singla, I. Alex Bowman, Christina Stevens, Guiyang Hao, James Brugarolas, Xiankai Sun
Publikováno v:
Clin Cancer Res
Purpose: Immune checkpoint inhibitors (ICI) targeting the programmed cell death protein 1 and its ligand (PD-1/PD-L1) have transformed the treatment paradigm for metastatic renal cell carcinoma (RCC). However, response rates to ICIs as single agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5bbf7f34210ae9cf5f7f4317daa594
https://europepmc.org/articles/PMC9669181/
https://europepmc.org/articles/PMC9669181/
Autor:
Cynthia M, Co, Aditi, Mulgaonkar, Ning, Zhou, Shelby, Harris, Orhan K, Öz, Liping, Tang, Xiankai, Sun
Publikováno v:
ACS infectious diseases. 8(8)
The increasing prevalence and severity of invasive fungal infections (IFIs), especially in immunocompromised populations, has amplified the need for rapid diagnosis of fungal pathogens. Radiotracers derived from d-amino acids (DAAs) show promise as b